Cover Story

The incidence of hepatocellular carcinoma (HCC) is increasing. This is proposed to be, in part, the result of the high prevalence of metabolic diseases. Dysregulated metabolism is an important contributor to the pathogenesis of cancer. Experimental models suggest that impeding glucose production promotes HCC, while enhancing glucose production has the opposite effect. The role of liver glycine N-methyltransferase (GNMT) in the relationship between glucose control and HCC is of particular interest. In humans with HCC, liver GNMT can be greatly decreased. Moreover, GNMT-null mice develop HCC by eight months of age suggesting a causal role for impaired GNMT action in tumorigenesis.

Hughey et al. studied the relationship of GNMT action and glucose production to HCC formation. The results show that the lack of GNMT reduces glucose production from glycogen and gluconeogenic sources. Reduced glucose production is coupled to impaired NAD+ synthesis and salvage. Results show a decline in NAD+ availability may diminish glucose production directly and/or by redirecting flux of glucose precursors to pathways that regulate liver redox state and tumorigenesis.

Full Text
The 60 Second Metabolist
In this section authors briefly report on their work recently published in Molecular Metabolism.

Watch the most recent interview by clicking the video still. The link "referring article" directs you to this author's publication.

Anne White, Jonathan Wray, Erika Harno
University of Manchester, UK
Referring article

Other Scientists...
Issue Alert
If you want to be alerted via email when new content that matches your interests is available, please login or register at
Conferences & Events
25 − 30
Epigenomics, Nuclear Receptors and Disease
Spetses Island, Greece
9 − 12
Ageing and Regeneration
Innsbruck, Austria
23 − 25
7th Helmholtz Diabetes Conference
Munich, Germany
15 − 18
Nature Conference: Advances in Metabolic Communication
Rio de Janeiro, Brasil
15 − 18
13th European Nutrition Conference
Dublin, Ireland
27 − 31
Metabolism in Action
Hillerod, Denmark
6 − 8
Cachexia, Sarcopenia and Muscle Wasting
Berlin, Germany
Media Coverage
Supported by